Development and characterization of colon specific drug delivery system bearing 5-ASA and camylofine dihydrochloride for the treatment of ulcerative colitis

By Dubey Rupal   Dubey Rounak   Omrey Pratibha   Vyas S.P.   Jain S.K.  

Journal of Drug Targeting, Vol. 18, Iss. 8, 2010-09 ,pp. : 589-601

Informa Healthcare

Access to resources Recommend Favorite

High mucosal healing rates in 5-ASA-treated ulcerative colitis patients: Results of a meta-analysis of clinical trials

By Römkens Tessa E.H.   Kampschreur Milou T.   Drenth Joost P.H.   van Oijen Martijn G.H.   de Jong Dirk J.  

Inflammatory Bowel Diseases, Vol. 18, Iss. 11, 2012-11 ,pp. : 2190-2198

Blackwell Publishing

Access to resources Recommend Favorite

Emerging drugs for the treatment of ulcerative colitis

By Pastorelli Luca   Pizarro Theresa T   Cominelli Fabio   Vecchi Maurizio  

Expert Opinion on Emerging Drugs, Vol. 14, Iss. 3, 2009-09 ,pp. : 505-521

Informa Healthcare

Access to resources Recommend Favorite

Treatment of steroid-naive ulcerative colitis

By Bossa Fabrizio   Colombo Elisabetta   Andriulli Angelo   Annese Vito  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 9, 2009-06 ,pp. : 1449-1460

Informa Healthcare

Access to resources Recommend Favorite

Novel therapies in the treatment of ulcerative colitis

By Tuvlin Jeffrey A   Kane Sunanda V  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 3, 2003-03 ,pp. : 483-490

Informa Healthcare

Access to resources Recommend Favorite